Literature DB >> 16861931

Regulation of PTEN function as a PIP3 gatekeeper through membrane interaction.

Francisca Vazquez1, Peter Devreotes.   

Abstract

PTEN, one of the most frequently mutated genes in human cancer, acts as a tumor suppressor by dephosphorylating the plasma membrane lipid second messenger phosphoinositide-3,4,5-trisphosphate (PIP3) generated by the action of PI3Kinases. PTEN activity to prevent elevated levels of PIP3 and tumorigenesis depends on its interaction with the lipid bilayer. PTEN binds dynamically to the plasma membrane through a complex mix of protein-lipid and protein-protein interactions and the translocation is regulated by several mechanisms including C-terminal tail phosphorylations. Here we have summarized our current view of the interaction of PTEN with the plasma membrane and what the implications are for cancer biology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861931     DOI: 10.4161/cc.5.14.3005

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  36 in total

1.  Activation of PI3K signaling in Merkel cell carcinoma.

Authors:  Valentina Nardi; Youngchul Song; Juan A Santamaria-Barria; Arjola K Cosper; Quynh Lam; Anthony C Faber; Genevieve M Boland; Beow Y Yeap; Kristin Bergethon; Vanessa L Scialabba; Hensin Tsao; Jeffrey Settleman; David P Ryan; Darrell R Borger; Atul K Bhan; Mai P Hoang; Anthony J Iafrate; James C Cusack; Jeffrey A Engelman; Dora Dias-Santagata
Journal:  Clin Cancer Res       Date:  2012-01-18       Impact factor: 12.531

2.  Coupling of Ci-VSP modules requires a combination of structure and electrostatics within the linker.

Authors:  Kirstin Hobiger; Tillmann Utesch; Maria Andrea Mroginski; Thomas Friedrich
Journal:  Biophys J       Date:  2012-03-20       Impact factor: 4.033

Review 3.  Big roles for small GTPases in the control of directed cell movement.

Authors:  Pascale G Charest; Richard A Firtel
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

4.  A pathogenic role for germline PTEN variants which accumulate into the nucleus.

Authors:  Janire Mingo; Isabel Rodríguez-Escudero; Sandra Luna; Teresa Fernández-Acero; Laura Amo; Amy R Jonasson; Roberto T Zori; José I López; María Molina; Víctor J Cid; Rafael Pulido
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

5.  Modeling self-organized spatio-temporal patterns of PIP₃ and PTEN during spontaneous cell polarization.

Authors:  Fabian Knoch; Marco Tarantola; Eberhard Bodenschatz; Wouter-Jan Rappel
Journal:  Phys Biol       Date:  2014-07-15       Impact factor: 2.583

6.  Analysis of the expression level and methylation of tumor protein p53, phosphatase and tensin homolog and mutS homolog 2 in N-methyl-N-nitrosourea-induced thymic lymphoma in C57BL/6 mice.

Authors:  Xueyun Huo; Zhenkun Li; Shuangyue Zhang; Changlong Li; Meng Guo; Jing Lu; Jianyi Lv; Xiaoyan Du; Zhenwen Chen
Journal:  Oncol Lett       Date:  2017-08-04       Impact factor: 2.967

7.  Involvement of the cytoskeleton in controlling leading-edge function during chemotaxis.

Authors:  Susan Lee; Zhouxin Shen; Douglas N Robinson; Steven Briggs; Richard A Firtel
Journal:  Mol Biol Cell       Date:  2010-04-07       Impact factor: 4.138

8.  Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases.

Authors:  Ana V Miletic; Amy N Anzelon-Mills; David M Mills; Sidne A Omori; Irene M Pedersen; Dong-Mi Shin; Jeffrey V Ravetch; Silvia Bolland; Herbert C Morse; Robert C Rickert
Journal:  J Exp Med       Date:  2010-10-18       Impact factor: 14.307

9.  Membrane association of the PTEN tumor suppressor: electrostatic interaction with phosphatidylserine-containing bilayers and regulatory role of the C-terminal tail.

Authors:  Siddharth S Shenoy; Hirsh Nanda; Mathias Lösche
Journal:  J Struct Biol       Date:  2012-10-13       Impact factor: 2.867

Review 10.  PTEN and the PI3-kinase pathway in cancer.

Authors:  Nader Chalhoub; Suzanne J Baker
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.